• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Tahara Hideaki  田原 秀晃

ORCIDConnect your ORCID iD *help
… Alternative Names

TAHARA HIDEAKI  田原 秀晃

TAHARA Hideaki  田原 秀晃

Less
Researcher Number 70322071
External Links
Affiliation (Current) 2022: 東京大学, 医科学研究所, 特任教授
Affiliation (based on the past Project Information) *help 2018 – 2022: 東京大学, 医科学研究所, 特任教授
2017: 東京大学, 医科学研究所, 教授
2000 – 2015: 東京大学, 医科学研究所, 教授
2007: 東京大学, 癌研究所・医科学研究所, 教授
Review Section/Research Field
Principal Investigator
Biological Sciences / General surgery / General surgery
Except Principal Investigator
General surgery / General surgery / Basic Section 50020:Tumor diagnostics and therapeutics-related / Digestive surgery / Biological Sciences / Digestive surgery / Ophthalmology … More / 医療における生命倫理 / Virology / Tumor therapeutics / Medium-sized Section 50:Oncology and related fields Less
Keywords
Principal Investigator
遺伝子治療 / 樹状細胞 / 腫瘍免疫 / サイトカイン / 免疫学 / GMP / がん治療 / tumor immunology / dendritic cells / adenoviral vector … More / 癌 / 生体機能利用 / 遺伝子 / NK細胞 / 実験外科学 / 臨床研究 / ウイルスベクター / IL-18 / Interleukin-12 / gene Therapy / Inteleukin-12 / translational research / バイオテクノロジー / 癌免疫療法 / 非特異的免疫 / 特異的免疫 / 細胞性免疫 / 自然免疫 / 獲得免疫 / 遺伝子導入 / NK-T細胞 / 細胞傷害性T細胞 / 細胞障害性T細胞 / 細胞療法 / ウィルスベクター / アデノウィルス・ベクター / レトロウィルス・ベクター / インターロイキン / in vivo electroporation / アデノウイル・スベクター / レトロウイルス・ベクター / gene therapy / cytokine / NK cells / retroviral vector / アデノウイルスベクター / 探索的医療 / IL-12 / 樹上細胞 / アデノウィルスベクター / RCA / がん免疫療法 / 腫瘍溶解性ウイルス療法 / 免疫 / トランスレーショナルリサーチ … More
Except Principal Investigator
遺伝子治療 / 樹状細胞 / Flt3L / HLA / dendritic cell / ウイルスベクター / SLC / がん / トランスレーショナル・リサーチ / in vivo electroporation / CTL / IL-18 / トランスレーショナルリサーチ / 免疫学 / ペプチド / マウス / 免疫寛容 / chemokine / peptide / regulatory T cell / CD4+CD25+ / thymus / 腫瘍溶解性ウイルス療法 / ヘルペスウイルス / 抗体 / GM-CSF / 細胞療法 / ウイルス / 遺伝子 / 高分子ミセル / 抗腫瘍効果 / DC / 移植 / トランスジェニックマウス / OK-432 / electroporation / RNA / 癌 / 免疫療法 / cancer / immunotherapy / エピトープペプチド / HER2 / neu / p53 / がんワクチン / がんワクチン療法 / Epitope peptide / Cancer vaccine / VEGFR2 / PKR / ras / VAI / CCL21 / がん免疫療法 / 免疫チェックポイント / MFG-E8 / 免疫遺伝子治療 / SEREX法 / cDNA発現ファージライブラリー / コモンマーモセット / 急性リンパ性白血病 / 成人T細胞性白血病 / LAM-PCR法 / SEREX / 腎癌腫瘍抗原 / SEREX抗原 / フィラデルフィア染色体陽性急性リンパ性白血病 / マキシザイム / VSV-Gシュードタイプレンチウイルスベクター / CD19リポソーム / bcr / abl遺伝子 / SAGE法 / 顆粒球マクロファージコロニー刺激因子遺伝子 / 抗コモンマーモセットCD34単クローン抗体 / BAI-1遺伝子 / p51遺伝子 / Tob遺伝子 / IL-18遺伝子 / アデノウイルスベクター / レトロウイルスベクター / 抗腫瘍免疫誘導 / 細胞傷害性T細胞 / 非ウイルスベクター / 癌抑制遺伝子 / カチオニックリポソーム / Qplex / C型肝炎ウイルス細胞障害領域 / LPD / Fusogenic peptide / カチオニックリボソーム / cGMP / 品質管理 / マネジメント・システム / TNF一α / YB-1 / CD40L / miRNA / TNF-α / TNF-α遺伝子 / ROS / Rac-1 / 再生医療 / 細胞医療 / 科学教育 / interleukin-23 / CTLA-4 / PD-1 / TIM-3 / IL-23 / 免疫監視機構 / 遺伝子導入 / 免疫制御 / 異所性心移植モデル / HLAクラスI抗原 / Peptide / Genetic modification / Dendritic Cell / Mouse / Transplantation / Tolerance / FasL(CD95L)導入癌細胞 / 癌遺伝子療法 / アポトーシス / 好中球浸潤 / MH134肝癌 / 抗Fas抗体 / 耐性腫瘍 / Fasリガンド発現腫瘍 / 抗腫瘍作用 / 肝癌MH134 / FasL発現腫瘍 / MH134 / FasL(CD95L)-transfected tumor cell / Cancer gene therapy / Apoptosis / Anti-tumor effect / Neutrophil infiltration / MH134 hepatoma / Anti-Fas antibody / Resistant tumor / インターロイキン 12 / インターロイキン12 / gene therapy / viral vector / interleukin-12 / ケモカイン / CCR7 / 腫瘍免疫 / 臓器移植 / 骨髄移植 / ビタミンD / tolerance / 骨髄非破壊的幹細胞移植 / dendritic cells / genetherapy / in vitro electroporation / denderitic cell / 組織適合性抗原 / 調節性T細胞 / CD4陽性CD25陽性 / 胸腺 / CD4+CD25+T細胞 / 心移植 / 移植免疫 / CD4CD25 / 制御性T cell / FoxP3 / transgenic mouse / 腫瘍の多様性 / HLA欠損 / 細胞障害性T細胞 / Tumor heterogenicity / HLA Loss / immunology / gene / translational research / virus / 加齢黄斑変性 / 光線力学療法 / 脈絡膜新生血管 / 特異的免疫賦活化療法 / サルゲノムマイクロアレイ / ナノバイオ / 移植・再生医療 / マイクロアレイ / age-related macular degeneration / photodynamic therapy / polyion complex micelle / choroidal neovascularization / genome microarray chips / アデノウイルス / ベクター / 膵がん / インターフェロン / IFN / Adenovirus / Vector / Gene Therapy / Pancreatic Cancer / Interferon / FIt3L / 利益相反 / 探索型医療 / インフォームド・コンセント / Conflict of Interest / Translational Research / Informed Consent / 腫瘍溶解ウイルス療法 / 造血器腫瘍 / PD-L1 / PD-L2 / 抗がん剤 / 化学免疫併用療法 / マクロファージ Less
  • Research Projects

    (39 results)
  • Research Products

    (154 results)
  • Co-Researchers

    (66 People)
  •  膜融合能増強型標的化ヘルペスウイルスのさらなる改変による抗腫瘍免疫誘導能の増強

    • Principal Investigator
      内田 宏昭
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      The University of Tokyo
  •  化学療法により誘導される免疫認識シグナル規定機構の解明と化学免疫併用療法への応用

    • Principal Investigator
      植松 美影 (濱田美影)
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      The University of Tokyo
  •  Treatment of metastatic tumors by systemic injection of tumor-retargeted oncolytic herpesviruses

    • Principal Investigator
      Uchida Hiroaki
    • Project Period (FY)
      2018 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      The University of Tokyo
  •  Development of oncolytic herpes simplex virus vectors retargeted to hematological malignancies

    • Principal Investigator
      Uchida Hiroaki
    • Project Period (FY)
      2018 – 2019
    • Research Category
      Grant-in-Aid for Challenging Research (Exploratory)
    • Review Section
      Medium-sized Section 50:Oncology and related fields
    • Research Institution
      The University of Tokyo
  •  Molecular mechanism of chemotherapy-induced immunosuppressive proteins expressions in esophageal cancer cells.

    • Principal Investigator
      Mika Hamada-Uematsu
    • Project Period (FY)
      2018 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      The University of Tokyo
  •  Development of cancer immunotherapy using hyperfusogenic receptor-retargeted HSVPrincipal Investigator

    • Principal Investigator
      TAHARA HIDEAKI
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Development of highly specific oncolytic herpes virus vectors by modification of two envelope glycoproteins

    • Principal Investigator
      Uchida Hiroaki
    • Project Period (FY)
      2015
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Virology
    • Research Institution
      The University of Tokyo
  •  T細胞不活化制御による癌に対する遺伝子細胞療法の開発

    • Principal Investigator
      松下 まりも (佐藤まりも / 佐藤 まりも / 松下 まりも(佐藤まりも))
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Augmentation of tumor specificity and killing activity of oncolytic herpes virus vectors

    • Principal Investigator
      Uchida Hiroaki
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Tumor therapeutics
    • Research Institution
      The University of Tokyo
      Tokyo University of Pharmacy and Life Science
  •  Development of quality prediction / rationalization system in autologous cell therapy which can conquer individual difference

    • Principal Investigator
      KATANO HISAKO
    • Project Period (FY)
      2010 – 2013
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Preclinical Development of Cellular Gene therapy using Viral VectorPrincipal Investigator

    • Principal Investigator
      TAHARA Hideaki
    • Project Period (FY)
      2009 – 2011
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Multidiciplinary TNF・a based gene therapy using polyplex micelle

    • Principal Investigator
      NAKA Nokenjl
    • Project Period (FY)
      2009 – 2011
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Digestive surgery
    • Research Institution
      Kyushu University
  •  Development of tumor-specific immunotherapy based on the analysis of functions of dendritic cellsPrincipal Investigator

    • Principal Investigator
      TAHARA Hideaki
    • Project Period (FY)
      2008 – 2009
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas
    • Review Section
      Biological Sciences
    • Research Institution
      The University of Tokyo
  •  The development of the quality evaluation system of gene-modified dendritic cells for cancer immunotherapy and gene therapy

    • Principal Investigator
      KATANO Hisako
    • Project Period (FY)
      2007 – 2008
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  樹状細胞機能の理解に基づく腫瘍特異的免疫誘導法の開発Principal Investigator

    • Principal Investigator
      田原 秀晃
    • Project Period (FY)
      2006 – 2007
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas
    • Review Section
      Biological Sciences
    • Research Institution
      The University of Tokyo
  •  New Treatment for Age-related Macular Degeneration Antiangiogenic Thereapy using Nanotechnology and Retianl Regenerative Therapy

    • Principal Investigator
      TAMAKI Yasuhiro
    • Project Period (FY)
      2006 – 2007
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Ophthalmology
    • Research Institution
      The University of Tokyo
  •  Development of the PKR-dependent replicating adenovirus

    • Principal Investigator
      SASAKI Katsunori
    • Project Period (FY)
      2006 – 2007
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Novel gene therapy by modulation of dendritic cells in vivo

    • Principal Investigator
      TAKUYA Takayama
    • Project Period (FY)
      2006 – 2007
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      Japanese Foundation For Cancer Research
  •  Analysis of the impact of Conflict of Interest on the determination of the patients and the patients right

    • Principal Investigator
      NAGAMURA Fumitaka
    • Project Period (FY)
      2006 – 2007
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      医療における生命倫理
    • Research Institution
      The University of Tokyo
  •  樹状細胞機能の理解に基づく腫瘍特異的免疫誘導法の開発Principal Investigator

    • Principal Investigator
      田原 秀晃
    • Project Period (FY)
      2005
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas
    • Review Section
      Biological Sciences
    • Research Institution
      The University of Tokyo
  •  Development of cancer immune-gene therapy using viral vector produced in Japanese academiaPrincipal Investigator

    • Principal Investigator
      TAHARA Hideaki
    • Project Period (FY)
      2005 – 2007
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Systemic disposition and induction of antitumor immunity with murine gene-modified dendritic cells

    • Principal Investigator
      KATANO Hisako
    • Project Period (FY)
      2005 – 2006
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  The role of CD4+CD25+T cells for immunological tolerance induction in organ transplantation

    • Principal Investigator
      BECK Yoshifumi
    • Project Period (FY)
      2004 – 2005
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Development for new cancer vaccine against heterogenicity and HLA-loss of tumor

    • Principal Investigator
      TSUNODA Takuya
    • Project Period (FY)
      2004 – 2005
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Digestive surgery
    • Research Institution
      The University of Tokyo
  •  NEW DEVELOPMENT OF DC IMMUNOTHERAPY TO UNIDENTIFIED CANCER ANTIGEN

    • Principal Investigator
      TAKAYAMA Takuya
    • Project Period (FY)
      2003 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  非特異的免疫機構を利用した腫瘍特異的免疫の誘導Principal Investigator

    • Principal Investigator
      田原 秀晃
    • Project Period (FY)
      2002 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas
    • Review Section
      Biological Sciences
    • Research Institution
      The University of Tokyo
  •  Clinical development of cancer gene therapy using viral vectorsPrincipal Investigator

    • Principal Investigator
      TAHARA Hideaki
    • Project Period (FY)
      2002 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Analysis of tolerance induction using immunosuppresslve dendritic cells in transplantation

    • Principal Investigator
      BECK Yoshifumi
    • Project Period (FY)
      2002 – 2003
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Cancer treatment by non-myeloablative hematopoietic stem cell transplant with Flt3L gene transfection.

    • Principal Investigator
      ANDO Yuichi
    • Project Period (FY)
      2002 – 2003
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Development for new cancer vaccine using various kinds of epitope peptides

    • Principal Investigator
      TSUNODA Takuya
    • Project Period (FY)
      2002 – 2003
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  非特異的免疫機構を利用した包括的な腫瘍特異的免疫治療の開発Principal Investigator

    • Principal Investigator
      田原 秀晃
    • Project Period (FY)
      2001
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas (C)
    • Review Section
      Biological Sciences
    • Research Institution
      The University of Tokyo
  •  臨床応用可能なウイルスベクター製造のための企画調査

    • Principal Investigator
      ICHIKAWA Naoya
    • Project Period (FY)
      2001
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Development of gene therapy using chemokine that regulates the mobilization of dendritic cells in situ

    • Principal Investigator
      TAKAYAMA Takuya
    • Project Period (FY)
      2001 – 2002
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  臨床用遺伝子導入ベクター開発を目的としたコモンマーモセット前臨床動物系の確立

    • Principal Investigator
      TANI Kenzaburou
    • Project Period (FY)
      2000 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas
    • Review Section
      Biological Sciences
    • Research Institution
      Kyushu University
      The University of Tokyo
  •  遺伝子治療用インテリジェント・リポソームシステムの開発

    • Principal Investigator
      柳衛 宏宣
    • Project Period (FY)
      2000 – 2001
    • Research Category
      Grant-in-Aid for Exploratory Research
    • Research Field
      Digestive surgery
    • Research Institution
      Teikyo University
      The University of Tokyo
  •  Adjuvant immuno-gene therapy for surgical treatment using dendritic cellsPrincipal Investigator

    • Principal Investigator
      TAHARA Hideaki
    • Project Period (FY)
      2000 – 2001
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Evaluation of in vivo tolerogenicity of genetically modified recipient dendritic cells (syngeneic DC) pulsed with immunogenic peptides (allopeptides) derived from donor HLA molecule in HLA class I transgenic mouse.

    • Principal Investigator
      BECK Yoshifumi
    • Project Period (FY)
      2000 – 2001
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo.
  •  Basic study for. Cancer Gene Therapy by Antitumor Effects Using Fas-Fas Ligand-Mediated Apoptosis

    • Principal Investigator
      TAKEDA Yasutaka
    • Project Period (FY)
      2000 – 2001
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Gene therapy for cancer using intratumoral injection of dendritic cells genetically modified to express interleukin 12

    • Principal Investigator
      ICHIKAWA Naoya
    • Project Period (FY)
      2000 – 2001
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo

All 2021 2019 2018 2017 2016 2015 2014 2012 2011 2010 2009 2008 2007 2005 2004 2003 2002 Other

All Journal Article Presentation Patent

  • [Journal Article] Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus2021

    • Author(s)
      Suzuki Takuma、Uchida Hiroaki、Shibata Tomoko、Sasaki Yasuhiko、Ikeda Hitomi、Hamada-Uematsu Mika、Hamasaki Ryota、Okuda Kosaku、Yanagi Shigeru、Tahara Hideaki
    • Journal Title

      Molecular Therapy - Oncolytics

      Volume: 22 Pages: 265-276

    • DOI

      10.1016/j.omto.2021.08.002

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K07319
  • [Journal Article] Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs2021

    • Author(s)
      Hitomi Ikeda, Hiroaki Uchida, Yu Okubo, Tomoko Shibata, Yasuhiko Sasaki, Takuma Suzuki, Mika Hamada -Uematsu, Ryota Hamasaki, Kosaku Okuda, Miki Yamaguchi, Masaki Kojima, Masato Tanaka, Hirofumi Hamada, Hideaki Tahara
    • Journal Title

      Journal of Virology

      Volume: 95

    • DOI

      10.1128/jvi.01766-20

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K07319, KAKENHI-PROJECT-18H02687
  • [Journal Article] NK cells control tumor-promoting function of neutrophils in mice.2018

    • Author(s)
      Ogura K, Sato-Matsushita M, Yamamoto S, Hori T, Sasahara M, Iwakura Y, Saiki I, Tahara H, Hayakawa Y.
    • Journal Title

      Cancer Immunology Research

      Volume: in press

    • NAID

      120006402039

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17H01578
  • [Journal Article] Immuno-regulatory influence of abundant MFG-E8 expression by esophageal cancer treated with chemotherapy.2018

    • Author(s)
      Kanemura Takashi、Miyata Hiroshi、Makino Tomoki、Tanaka Koji、Sugimura Keijiro、Hamada-Uematsu Mika、Mizote Yu、Uchida Hiroaki、Miyazaki Yasuhiro、Takahashi Tsuyoshi、Kurokawa Yukinori、Yamasaki Makoto、Wada Hisashi、Nakajima Kiyokazu、Takiguchi Shuji、Mori Masaki、Doki Yuichiro、Tahara Hideaki
    • Journal Title

      Cancer Science

      Volume: 109 Pages: 224-228

    • DOI

      10.1111/cas.13785

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K07319, KAKENHI-PROJECT-17H01578
  • [Journal Article] Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain2017

    • Author(s)
      Kaneko MK, Abe S, Ogasawara S, Fujii Y, Yamada S, Murata T, Uchida H, Tahara H, Nishioka Y, Kato Y.
    • Journal Title

      Monoclon Antib Immunodiagn Immunothe

      Volume: 36(1) Pages: 25-29

    • DOI

      10.1089/mab.2016.0047

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-26440019, KAKENHI-PROJECT-17H01578, KAKENHI-PROJECT-16H05309
  • [Journal Article] Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma2017

    • Author(s)
      Yamazaki Naoya、Kiyohara Yoshio、Uhara Hisashi、Iizuka Hajime、Uehara Jiro、Otsuka Fujio、Fujisawa Yasuhiro、Takenouchi Tatsuya、Isei Taiki、Iwatsuki Keiji、Uchi Hiroshi、Ihn Hironobu、Minami Hironobu、Tahara Hideaki
    • Journal Title

      Cancer Science

      Volume: 108 Pages: 1022-1031

    • DOI

      10.1111/cas.13226

    • NAID

      120006373754

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K10165, KAKENHI-PROJECT-17H01578
  • [Journal Article] Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity2017

    • Author(s)
      Kato Y, Kunita A, Fukayama M, Abe S, Nishioka Y, Uchida H, Tahara H, Yamada S,Yanaka M, Nakamura T, Saidoh N, Yoshida K, Fujii Y, Honma R, Takagi M, Ogasawara S, Murata T, Kaneko MK.
    • Journal Title

      Monoclon Antib Immunodiagn Immunother

      Volume: 36(1) Pages: 20-24

    • DOI

      10.1089/mab.2016.0045

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-26440019, KAKENHI-PROJECT-17H01578, KAKENHI-PROJECT-16H05309, KAKENHI-PROJECT-15K10459
  • [Journal Article] Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.2016

    • Author(s)
      Shibata T, Uchida H, Shiroyama T, Okubo Y, Suzuki T, Ikeda H, Yamaguchi M, Miyagawa Y, Fukuhara T, Cohen JB, Glorioso JC, Watabe T, Hamada H, Tahara H.
    • Journal Title

      Gene Therapy

      Volume: 印刷中 Pages: 479-488

    • DOI

      10.1038/gt.2016.17

    • Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K15144, KAKENHI-PROJECT-25290059, KAKENHI-PROJECT-15K06876, KAKENHI-PROJECT-16K08249, KAKENHI-PROJECT-16K07184
  • [Journal Article] 大腸癌の遺伝子治療・ウイルス療法2015

    • Author(s)
      内田宏昭, 田原秀晃
    • Journal Title

      日本臨床

      Volume: 1077 Pages: 569-573

    • Data Source
      KAKENHI-PROJECT-25290059
  • [Journal Article] 大腸癌の遺伝子治療・ウイルス療法2015

    • Author(s)
      内田宏昭, 田原秀晃
    • Journal Title

      日本臨床

      Volume: 1077 Pages: 569-573

    • Data Source
      KAKENHI-PROJECT-15K15144
  • [Journal Article] TLR3/TICAM-1 signaling converts tumor-supporting myeloid cells to tumoricidal Effectors2012

    • Author(s)
      H.Shime
    • Journal Title

      Proc Natl Acad Sci U S A.

      Volume: 109 Pages: 2066-2071

    • DOI

      10.1073/pnas.1113099109

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20220009, KAKENHI-PROJECT-21200079, KAKENHI-PROJECT-21249069, KAKENHI-PROJECT-21590326, KAKENHI-PUBLICLY-22021002, KAKENHI-PLANNED-22114008, KAKENHI-PUBLICLY-22117501, KAKENHI-PROJECT-22790371, KAKENHI-PROJECT-22790450, KAKENHI-PROJECT-23390120, KAKENHI-PROJECT-23590558, KAKENHI-PROJECT-24590470, KAKENHI-PROJECT-24659214
  • [Journal Article] Early activation and IFN-γproduction of tumor infiltrating mature CD27high NK cells2011

    • Author(s)
      Y.Hayakawa
    • Journal Title

      Cancer Sci.

      Volume: 102 Pages: 1967-1971

    • DOI

      10.1111/j.1349-7006.2011.02042.x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20220009, KAKENHI-PROJECT-21249069, KAKENHI-PROJECT-22659016, KAKENHI-PUBLICLY-23112519, KAKENHI-PROJECT-23300355, KAKENHI-PROJECT-23701073
  • [Journal Article] Tumor-associated macrophages regulate tumorigenicity and anticancer drugresponses of cancer stem/initiating cells2011

    • Author(s)
      Jinushi M, Chiba S, Yoshiyama H, Masutomi K, Kinoshita I, Dosaka-Akita H, Yagita H, Takaoka A, Tahara H.
    • Journal Title

      Proc Natl Acad Sci U S A

      Volume: 108巻 Pages: 112425-12430

    • DOI

      10.1073/pnas.1106645108

    • NAID

      10030575946

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069, KAKENHI-PROJECT-21689031, KAKENHI-PROJECT-22240089, KAKENHI-PUBLICLY-23130501, KAKENHI-PROJECT-23590534, KAKENHI-PROJECT-23591132
  • [Journal Article] MicroRNA-based gene regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor2011

    • Author(s)
      Hikichi M, Kidokoro M, Haraguchi T, Iba H, Shida H, Tahara H & Nakamura T.
    • Journal Title

      Molecular Therapy

      Volume: 19巻 Pages: 1107-1115

    • DOI

      10.1038/mt.2011.36

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069, KAKENHI-PROJECT-22659227, KAKENHI-PROJECT-22680065, KAKENHI-PROJECT-22700873, KAKENHI-PUBLICLY-23130504
  • [Journal Article] Proatherogenic effect of interleukin-18 is exerted with high-fat diet, but not with normal diet in spontaneously hyperlipidemic mice2011

    • Author(s)
      Imai T, Oikawa Y, Shimada A, Oguchi S, Takamiya Y, Katsuki T, Okubo Y, Osaki T, Tahara H, Matsushima Y, Miyazaki J, Itoh H
    • Journal Title

      J Atheroscler Throimb

      Volume: 18 Pages: 1090-101

    • NAID

      130004845359

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor2011

    • Author(s)
      Nakano K, Kobayashi M, Nakamura K, Nakanishi T, Asano R, Kumagai I, Tahara H, Kuwano M, Cohene JB, Glorioso JC
    • Journal Title

      Virology

      Volume: 413 Pages: 2-18

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Cohen IB2011

    • Author(s)
      Nakano K, Kobayashi M, Nakamura K, Nakanishi T, Asa no R, Kumagai 1, Tahara H, Kuwano
    • Journal Title

      Glorioso JC : Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor

      Volume: 413(1) Pages: 12-18

    • Data Source
      KAKENHI-PROJECT-21390374
  • [Journal Article] Ex-vivo expanded DC induce donor-specific central and peripheral tolerance and prolong the acceptance of donor skin allografts.2011

    • Author(s)
      Yamano T, Watanabe S, Hasegawa H, Suzuki T, Abe R, Tahara H, Nitta T, Ishimaru N, Sprent J, Kishimoto H.
    • Journal Title

      Blood

      Volume: (in press)(掲載確定)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor2011

    • Author(s)
      Nakano K, Kobayashi M, Nakamura K, Nakanishi T, Asano R, Kumagai I, Tahara H, Kuwano M, Cohen JB, Glorioso JC
    • Journal Title

      Virology

      Volume: 413 Pages: 12-18

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21390374
  • [Journal Article] Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor2011

    • Author(s)
      Nakano K, Kobayashi M, Nakamura K, Nakanishi T, Asano R, Kumagai I, Tahara H, Kuwano M, Cohene JB, Glorioso JC.
    • Journal Title

      Virology

      Volume: 413巻 Pages: 12-18

    • DOI

      10.1016/j.virol.2011.02.014

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069, KAKENHI-PROJECT-22226013, KAKENHI-PROJECT-23686118
  • [Journal Article] MicroRNA regulation of vaccinia virus for enhanced oncolytic activity and reduced pathogenicity in oncolytic virotherapy2011

    • Author(s)
      Hikichi M, Kidokoro M, Haraguchi T, Iba H, Shida H, Tahara H, Nakamura T.
    • Journal Title

      Molecular Therapy

      Volume: (In press)(掲載確定)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor.2011

    • Author(s)
      Nakano K, Kobayashi M, Nakamura K, Nakanishi T, Asano R, Kumagai I, Tahara H, Kuwano M, Cohene JB, Glorioso JC.
    • Journal Title

      Virology

      Volume: 413 Pages: 2-18

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Proatherogenic Effect of Interleukin-18 is Exerted with High-fat Diet, but not with Normal Diet in Spontaneously Hyperlipidemic Mice2011

    • Author(s)
      Imai T, Oikawa Y, Shimada A, Oguchi S, Takamiya Y, Katsuki T, Okubo Y, Osaki T, Tahara H, Matsushima Y, Miyazaki J, Itoh H.
    • Journal Title

      J Atheroscler Thromb

      Volume: 18巻 Issue: 12 Pages: 1090-101

    • DOI

      10.5551/jat.7567

    • NAID

      130004845359

    • ISSN
      1340-3478, 1880-3873
    • Language
      English
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Ex-vivo expanded DC induce donor-specific central and peripheral tolerance and prolong the acceptance of donor skin allografts2011

    • Author(s)
      Takahama Y
    • Journal Title

      Blood

      Volume: 118 Pages: 2380-2381

    • DOI

      10.1182/blood-2010-07-293860

    • Peer Reviewed
    • Data Source
      KAKENHI-PLANNED-19059010, KAKENHI-PROJECT-21249069, KAKENHI-PROJECT-23249025
  • [Journal Article] Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*24022010

    • Author(s)
      Baba T, Sato-Matsushita M, Kanamoto A, Itoh A, Oyaizu N, Inoue Y, Kawakami Y, Tahara H
    • Journal Title

      J Translational Medicine

      Volume: 8 Pages: 84-95

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A* 24022010

    • Author(s)
      Baba T, Sato-Matsushita M, Kanamoto A, Itoh A, Oyaizu N, Inoue Y, Kawakami Y, Tahara H.
    • Journal Title

      J Translational Medicine

      Volume: 8巻 Pages: 84-95

    • DOI

      10.1186/1479-5876-8-84

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Cytokine gene-mediated immunotherapy : Current status and future perspectives.2009

    • Author(s)
      Jinushi M, Tahara H
    • Journal Title

      Cancer Science 100

      Pages: 1389-1396

    • NAID

      10027192998

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Emerging concepts in biomarker discovery ; The US-Japan workshop on immunological molecular markers in oncology2009

    • Author(s)
      Tahara H, et al
    • Journal Title

      Journal of Translational Medicine

      Volume: 7巻 Pages: 1389-1396

    • DOI

      10.1186/1479-5876-7-45

    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Milk Fat Globule EGF-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms.2009

    • Author(s)
      Jinushi M, Sato M, Kanamoto A, Itoh A, Nagai S, Koyasu S, Dranoff G, Tahara H.
    • Journal Title

      J Exp. Med. 206

      Pages: 1317-1326

    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] Cytokine gene-mediated immunotherapy : Current status and future perspectives2009

    • Author(s)
      Jinushi M, Tahara H
    • Journal Title

      Cancer Science

      Volume: 100巻 Pages: 1389-1396

    • DOI

      10.1111/j.1349-7006.2009.01202.x

    • NAID

      10027192998

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Emerging concepts in biomarker discovery2009

    • Author(s)
      Tahara H., et, al
    • Journal Title

      J Translational Med 7

      Pages: 45-69

    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] Cytokine gene-mediated immunotherapy: Current status and future perspectives.2009

    • Author(s)
      Jinushi M, Tahara H
    • Journal Title

      Cancer Science 100

      Pages: 1389-1396

    • NAID

      10027192998

    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] Emerging concepts in biomarker discovery ; The US-Japan workshop on immunological molecular markers in oncology2009

    • Author(s)
      Tahara H., et al.(56 authors in total)
    • Journal Title

      Journal of Translational Medicine 7

      Pages: 45-69

    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Milk-fat globule EGF-8 triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms2009

    • Author(s)
      Jinushi M, Sato M, Kanamoto A, Itoh A, Nagai S, Koyasu S, Dranoff G, and Tahara H.
    • Journal Title

      J. Exp. Med.

      Volume: 100巻 Pages: 1317-1326

    • DOI

      10.1084/jem.20082614

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069, KAKENHI-PROJECT-21689031
  • [Journal Article] Emerging concepts in biomarker discovery ; The US-Japan workshop on immunological molecular markers in oncology2009

    • Author(s)
      Tahara H., et al.(56 authors in total)
    • Journal Title

      Journal of Translational Medicine 7

      Pages: 45-69

    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] Cytokine gene-mediated immunotherapy : Current status and future perspe dives2009

    • Author(s)
      Jinushi M, Tahara H.
    • Journal Title

      Cancer Science 100

      Pages: 1389-1396

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] Milk Fat Globule EGF-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms.2009

    • Author(s)
      Jinushi M, Sato M, Kanamoto A, Itoh A, Nagai S, Koyasu S, Dranoff G, Tahara H.
    • Journal Title

      Journal of Experimental Medicine 100

      Pages: 1389-1396

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Journal Article] Milk Fat Globule EGF-8 blockade triggers tumor destruction through coor dinated cell-autonomous and immune-mediated mechanisms2009

    • Author(s)
      Jinushi M, Sato M, Kanamoto A, Itoh A, Nagai S, Koyasu S, Dranoff G, Tahara H.
    • Journal Title

      Journal of Experimental Medicine 100

      Pages: 1389-1396

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.2008

    • Author(s)
      Suda T, Tahara H, et. al.
    • Journal Title

      Cancer Sci(掲載確実)

    • NAID

      10020119420

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Journal Article] Vaccination with epitope peptide derived from human VEGF receptor 2 prevent choroidal neovascularization in an animal model2008

    • Author(s)
      Takahashi H, Tahara H, et. al.
    • Journal Title

      Investigative Ophthalmology & Vis Science (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Journal Article] Vaccination with epitope peptide derived from human VEGF receptor 2 prevent choroidal neovascularization in an animal model.2008

    • Author(s)
      Takahashi H, Tahara H, et. al.
    • Journal Title

      Investigative Ophthalmology & Visual Science(掲載確実)

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Journal Article] 「研究成果報告書概要(欧文)」より2008

    • Author(s)
      Saito T, Takayama T, Osaki T, Nagai S, Suzuki T, Sato M, Kuwano H, Tahara H
    • Journal Title

      Cancer Sci. 99

      Pages: 2028-36

    • Data Source
      KAKENHI-PROJECT-17209042
  • [Journal Article] Identification of human leukocyte antigen-A24-restricted epitope peputides derived from gene products upregulated in lung and esophageal vancers as novel targets for immunology.2008

    • Author(s)
      Suda T., Tahara H., et. al.
    • Journal Title

      Cancer Sci 9(掲載確定)

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Journal Article] Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.2008

    • Author(s)
      Suda T, Tahara H, et. al.
    • Journal Title

      Cancer Sci (掲載確実)

    • NAID

      10020119420

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Journal Article] Combined mobilization and stimulation of tumor-infiltrating dendritic cells and natural killer cells with Flt3 ligand and IL-18 in vivo induces systemic anti-tumor immunity2008

    • Author(s)
      Saito T, Takayama T, Osaki T, Nagai S, Suzuki T, Sato M, Kuwano H, Tahara H.
    • Journal Title

      Cancer Science 99

      Pages: 2028-2036

    • NAID

      10024012190

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] 「研究成果報告書概要(欧文)」より2008

    • Author(s)
      Suzuki T, Ogawa S, Tanabe K, Tahara H, Abe R, Kishimoto H
    • Journal Title

      J Immunol 180

      Pages: 4596-4605

    • Data Source
      KAKENHI-PROJECT-17209042
  • [Journal Article] Suppression of choroidal neovascularization by vaccination with epitope peptide derived from human VEGF receptor 2 in an animal model.2008

    • Author(s)
      Takahashi H, Ishizaki H, Tahara H, Tamaki Y, Yanagi Y.
    • Journal Title

      Investigtive Ophthalmology & Visual Science 49

      Pages: 2143-2147

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18390465
  • [Journal Article] Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy2008

    • Author(s)
      Suda T, Tahara H, et. al.
    • Journal Title

      Cancer Sci (in press)

    • NAID

      10020119420

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Journal Article] Vaccination with Epitope Peptide Derived from Human VEGF Receptor 2 Prevent Choroidal Neovascularization in an Animal Model.2008

    • Author(s)
      Takahashi H, Ishizaki H, Tahara H, Tamaki Y, Yanagi Y.
    • Journal Title

      Investigative Ophthalmology & Visual Science 49

      Pages: 2143-2147

    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] Suppression of choroidal neovascularization by vaccination with epitope peptide derived from hu2008

    • Author(s)
      Takahashi H, IshizakiH, TaharaH, Tamak
    • Journal Title

      Investigtive Ophthalmology & Visual Science 49

      Pages: 2143-2147

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18390465
  • [Journal Article] Suppression of choroidal neovascularization by vaccination with epitope peptide derived from human VEGF receptor 2 in an animal model.2008

    • Author(s)
      Takahashi H. Ishizaki H, Tahara H. Tamaki Y. Yanagi Y.
    • Journal Title

      Investigtive Ophthalmology & Visual Science 49

      Pages: 2143-2147

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-18390465
  • [Journal Article] Combined mobilization and stimulation of tumor-infiltrating dendritic cells and natural killer cells with Flt3 ligand and IL-18 in vivo induces systemic anti-tumor immunity.2008

    • Author(s)
      Saito T, Takayama T, Osaki T, Nagai S, Suzuki T, Sato M, Kuwano H, Tahara H.
    • Journal Title

      Cancer Sci. 99

      Pages: 2028-36

    • NAID

      10024012190

    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] Induction of anti-tumor immune response by homeostatic proliferation and CD28 signaling.2008

    • Author(s)
      Suzuki T, Ogawa S, Tanabe K, Tahara H, Abe R, Kishimoto H.
    • Journal Title

      J Immunol 180

      Pages: 4596-4605

    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] Induction of and-tumor immune response by homeostatic prolifer ation and CD28 sianalina2008

    • Author(s)
      Suzuki T, Ogawa S, Tanabe K, Tahara H. Abe R.Kishimoto H
    • Journal Title

      J Immunology 180

      Pages: 4596-4605

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] Induction of anti-tumor immune response by homeostatic proliferation and CD28 signaling.2008

    • Author(s)
      Suzuki T, Ogawa S, Tanabe K, Tahara H, Abe R, Kishimoto H.
    • Journal Title

      J Immunology 180

      Pages: 4596-4605

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17209042
  • [Journal Article] Identification of human leukocyte antigen-A24-restricted epitope peputides derived from gene products upregulated in lung and esophageal vancers as novel targets for immunology2008

    • Author(s)
      Suda T., Tahara H., et. al.
    • Journal Title

      Cancer Sci (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Journal Article] Identification of human leukocyte antigen-A24-restricted epitope peputides derived from gene products upregulated in lung and esophageal vancers as novel targets for immunology.2008

    • Author(s)
      Suda T., Tahara H., et. al.
    • Journal Title

      Cancer Sci(掲載確実) 9

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Journal Article] Combined mobilization and stimulation of tumor-infiltrating dendritic cells and natural killer cells with Flt3 ligand and IL-18 in vivo induces systemic anti-tumor immunity.2008

    • Author(s)
      Saito T, Takayama T, Osaki T, Nagai S, Suzuki T, Sato M, Kuwano H, Tahara H.
    • Journal Title

      Cancer Science 99

      Pages: 2028-2036

    • NAID

      10024012190

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17209042
  • [Journal Article] Syastemic administration of IL23 induces potent antitumor immunity primary mediated through Th1-type response in association with the endogenously expressed IL-12.2007

    • Author(s)
      Kaiga T, Tahara H, et. al.
    • Journal Title

      J Immunol 178

      Pages: 751-80

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Journal Article] Systemic Administration of IL-23 Induces Potent Anti-tumor Immunity Primarily Mediated through Th1-type Response in Association with the Endogeno usiy Expressed IL-12.2007

    • Author(s)
      Kaiga T, Sato M, Kaneda H, Iwakura Y, Takayama T, Tahara H.
    • Journal Title

      J Immunology 178

      Pages: 7571-80

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17209042
  • [Journal Article] Systemic Administration of IL-23 Induces Potent Anti-tumor Immunity Primarily Mediated through Th1-type Response in Association with the Endogenously Expressed IL-122007

    • Author(s)
      Kaiga T, Sato M, Kaneda H, Iwakura Y, Takayama T, Tahara H
    • Journal Title

      J Immunol 178

      Pages: 7571-7580

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17209042
  • [Journal Article] 「研究成果報告書概要(欧文)」より2007

    • Author(s)
      Kaiga T, Sato M, Kaneda H, Iwakura Y, Takayama T, Tahara H
    • Journal Title

      J Immunol 178

      Pages: 7571-7580

    • Data Source
      KAKENHI-PROJECT-17209042
  • [Journal Article] Syastemic administration of IL23 induces potent antitumor immunity primary mediated through Th1-type response in association with the endogenously expressed IL-122007

    • Author(s)
      Kaiga T, Tahara H, et. al.
    • Journal Title

      J Immunol 178

      Pages: 751-80

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Journal Article] Identification of HLA-A24-restricted epitope-peptides derived from gene products up-regulated in lung and esophageal cancers as novel targets for immunotherapy2007

    • Author(s)
      Suda T, Tsunoda T, Daigo Y, Nakamura Y, Tahara H
    • Journal Title

      Cancer Science 98

      Pages: 1803-1908

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17209042
  • [Journal Article] Cancer gene therapy using in vivo electroporation of Flt3-Ligand.2005

    • Author(s)
      Shimao K, Takayama T, Enomoto K, Saito T, Nagai S, Miyazaki J, Ogawa K, Tahara H.
    • Journal Title

      Int.J Oncol. (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-15591330
  • [Journal Article] Dendritic cell might be one of key factors for eliciting antitumor effect by chemo-immunotherapy in vivo.2005

    • Author(s)
      Mushiake H, Tahara H.他6名
    • Journal Title

      Cancer Immunology Immunotherapy (in press)

    • Data Source
      KAKENHI-PROJECT-14030010
  • [Journal Article] Dendritic cell might be one of key factors for eliciting antitumor effect by chemo-immunotherapy in vivo.2005

    • Author(s)
      Mushiake H, Tsunoda T, Nukatsuka M, Shimao K, Fukushima M, Tahara H.
    • Journal Title

      Cancer Immunology Immunotherapy 54

      Pages: 120-128

    • Data Source
      KAKENHI-PROJECT-17016025
  • [Journal Article] Cancer gene therapy using in vivo electroporation of Flt3-Ligand.2005

    • Author(s)
      Shimao K, Takayama T, Enomoto K, Saito T, Nagai S, Miyazaki J, Ogawa K, Tahara H.
    • Journal Title

      Int J Oncology 27

      Pages: 457-463

    • Data Source
      KAKENHI-PROJECT-17209042
  • [Journal Article] Cancer gene therapy using in vivo electroporation of Flt3-Ligand.2005

    • Author(s)
      Shimao K, Tahara H.他8名
    • Journal Title

      Int J Oncology (in press)

    • Data Source
      KAKENHI-PROJECT-14030010
  • [Journal Article] Dendritic cell might be one of key factors for eliciting antitumor effect by chemo-immunotherapy in vivo.2005

    • Author(s)
      Mushiake H, Tsunoda T, Nukatsuka M, Shimao K, Fukushima M, Tahara H.
    • Journal Title

      Cancer Immunology Immunotherapy 54

      Pages: 120-128

    • Data Source
      KAKENHI-PROJECT-17209042
  • [Journal Article] Cancer gene therapy using in vivo electroporation of Flt3-Ligand.2005

    • Author(s)
      Shimao K, Takayama T, Enomoto K, Saito T, Nagai S, Miyazaki J, Ogawa K, Tahara H.
    • Journal Title

      Int J Oncology 27

      Pages: 457-463

    • Data Source
      KAKENHI-PROJECT-17016025
  • [Journal Article] Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo.2004

    • Author(s)
      Uchida H, Tahara H, 他9名
    • Journal Title

      Mol Ther. 10

      Pages: 162-171

    • Data Source
      KAKENHI-PROJECT-14030010
  • [Journal Article] Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan : clinical and immunological findings2004

    • Author(s)
      Tani K, Tahara H, 他35名
    • Journal Title

      Mol Ther. 10

      Pages: 799-816

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Adenoyirus-mediated transfer of siRNA against survivin induced appptosis and attenuated tumor cell growth in vitro and in vivo.2004

    • Author(s)
      Uchida H, Tahara H, et al.
    • Journal Title

      Mol Ther. 10

      Pages: 162-171

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell arowth in vitro and in vivo.2004

    • Author(s)
      Uchida H, Tahara H, 他9名
    • Journal Title

      Mol Ther. 10

      Pages: 162-171

    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo.2004

    • Author(s)
      Uchida H, Tahara H, 他9名
    • Journal Title

      Mol Ther. 10

      Pages: 162-171

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Generation of Mature Dendritic Cells Fully Capable of T Helper Type 1 Polarization Using OK-432 Combined with Prostaglandin E2.2004

    • Author(s)
      Sato M, Tahara H.他2名
    • Journal Title

      Cancer Science 94

      Pages: 1091-1098

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan : clinical and immunological findings.2004

    • Author(s)
      Tani K, Tahara H, et al.
    • Journal Title

      Mol Ther. 10

      Pages: 799-816

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Ring finger protein (RNF) 43 as a New Target for Cancer Immunotherapy Clinical2004

    • Author(s)
      Uchida N, Tahara H.他6名
    • Journal Title

      Cancer Research 10

      Pages: 8577-8586

    • Data Source
      KAKENHI-PROJECT-14030010
  • [Journal Article] Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan : clinical and immunological findings2004

    • Author(s)
      Tani K, Tahara H, 他35名
    • Journal Title

      Mol Ther. 10

      Pages: 799-816

    • Data Source
      KAKENHI-PROJECT-14030010
  • [Journal Article] Phase I study of autologous tumor vaccines transduced with the GM-C SF gene in four patients with stage IV renal cell cancer in Japan : clinical and immunological finding2004

    • Author(s)
      Tani K, Tahara H, 他35名
    • Journal Title

      Mol Ther. 10

      Pages: 799-816

    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide.2003

    • Author(s)
      Nakahara S, Tahara H.他3名
    • Journal Title

      Cancer Research 63

      Pages: 4112-4118

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Dendritic cells stimulated with a bacterial product, OK-432,efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide.2003

    • Author(s)
      Nakahara S, Tahara H, et al.
    • Journal Title

      Cancer Research 63

      Pages: 4112-4118

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Hydrodynamics-based delivery of the viral interleukin-10 genesuppressesexperimental crescentic glomerulonephritis in Wistar-Kyoto rats.2003

    • Author(s)
      Higuchi N, Tahara H, et al.
    • Journal Title

      Gene Ther. 10

      Pages: 1297-1310

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Differential effects of IL-12 on the generation of alloreactive CTL mediated by murine and human dendritic cells : a critical role for nitric oxide.2003

    • Author(s)
      Nishioka Y, Tahara H, et al.
    • Journal Title

      J Leukoc Biol 73

      Pages: 621-629

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Interleukin-17 promotes angiogenesis and tumor growth.2003

    • Author(s)
      Numasaki M.Tahara H, et al.
    • Journal Title

      Blood 101

      Pages: 2620-2627

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] NK but not NKT cells play a necessary role to promote an innate antitumor response induced by IL-18.2003

    • Author(s)
      Hashimoto W, Tahara H.他5名
    • Journal Title

      Int J Cancer 103

      Pages: 508-513

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Generation of Mature Dendritic Cells Fully Capable of T Helper Type 1 Polarization Using OK-432 Combined with Prostaglandin E2.2003

    • Author(s)
      Sato M, Tahara H, et al.
    • Journal Title

      Cancer Science 94

      Pages: 1091-1098

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Generation of Mature Dendritic Cells Fully Capable of T Helper Type 1 Polarization Using OK-432 Combined with Prostaglandin E2.2003

    • Author(s)
      Sato M, Takayama T, Tanaka H, Konishi J, Suzuki T, Kaiga T, Tahara H.
    • Journal Title

      Cancer Sci 94

      Pages: 1091-1098

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-15591330
  • [Journal Article] Interleukin-17 promotes angiogenesis and tumor growth.2003

    • Author(s)
      Numasaki M, Tahara H.他7名
    • Journal Title

      Blood 101

      Pages: 2620-2627

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] NK but not NKT cells play a necessary role to promote an innate antitumor response induced by IL-18.2003

    • Author(s)
      Hashimoto W, Tahara H, et al.
    • Journal Title

      Int J Cancer 103

      Pages: 508-513

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Differential effects of IL-12 on the generation of alloreactive CTL mediated by murine and human dendritic cells : a critical role for nitric oxide.2003

    • Author(s)
      Nishioka Y, Tahara H.他5名
    • Journal Title

      J Leukoc Biol 73

      Pages: 621-629

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar-Kyoto rats.2003

    • Author(s)
      Higuchi N, Tahara H, 他9名
    • Journal Title

      Gene Ther 10

      Pages: 1297-1310

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Retroviral delivery of transforming growth factor-β1 to myeloid dendritic cells ; inhibition of T cell priming ability and influence on allograft survival.2002

    • Author(s)
      Takayama T, Tahara H.他4名
    • Journal Title

      Transplantation 74

      Pages: 112-119

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.2002

    • Author(s)
      Tanaka F, Tahara H, et al.
    • Journal Title

      Gene Ther 9

      Pages: 1480-1486

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Construction and Analysis of New Vector Systems with Improved Interleukin-18 Secretion in Xenogeneic Human Tumor Model2002

    • Author(s)
      Goto H, Tahara H, et al.
    • Journal Title

      J Immunother 25 Suppl 1

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Retroviral delivery of transforming growth factor-β 1 to myeloid dendritic cells ; inhibition of T cell priming ability and influence on allograft survival.2002

    • Author(s)
      Takayama T, Tahara H, et al.
    • Journal Title

      Transplantation 74

      Pages: 112-119

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.2002

    • Author(s)
      Tanaka F, Tahara H.他3名
    • Journal Title

      Gene Ther 9

      Pages: 1480-1486

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Construction and Analysis of New Vector Systems with Improved Interleukin-18 Secretion in Xenogeneic Human Tumor Model2002

    • Author(s)
      Goto H, Tahara H.他8名
    • Journal Title

      J Immunother 25 Suppl 1

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14207047
  • [Journal Article] Milk Fat Globule EGF-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms

    • Author(s)
      inushi M, Sato M, Kanamoto A, Itoh A, Nagai S, Koyasu S, Dranoff G, and Tahara H
    • Journal Title

      J Experimental Medicine (In press)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Journal Article] Intrathymic Inoculation of Donor HLA Class-1 derived Peptide Generates Donor-Specific CD4+CD25+ regulatory T cells.

    • Author(s)
      S.Tamura, Y.Beck, Y.Ando, H.Tahara
    • Journal Title

      Transplantation Proc (In press)

    • Data Source
      KAKENHI-PROJECT-16591248
  • [Journal Article] Syastemic administration of IL23 induces potent antitumor immunity primary mediated through Th1-type response in association with the endogenously expressed IL-12

    • Author(s)
      Kaiga T, Tahara H, et. al.
    • Journal Title

      J Immunol

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Patent] がん治療のための腫瘍溶解性ウイルス2019

    • Inventor(s)
      内田宏昭・田原秀晃
    • Industrial Property Rights Holder
      内田宏昭・田原秀晃
    • Industrial Property Rights Type
      特許
    • Filing Date
      2019
    • Overseas
    • Data Source
      KAKENHI-PROJECT-18K19468
  • [Patent] がん治療のための腫瘍溶解性ウイルス2019

    • Inventor(s)
      内田宏昭・田原秀晃
    • Industrial Property Rights Holder
      内田宏昭・田原秀晃
    • Industrial Property Rights Type
      特許
    • Filing Date
      2019
    • Overseas
    • Data Source
      KAKENHI-PROJECT-18H02687
  • [Patent] 脈絡膜新生血管のワクチン療法2008

    • Inventor(s)
      玉置泰裕, 田原秀晃
    • Industrial Property Rights Holder
      東京大学
    • Filing Date
      2008-02-15
    • Description
      「研究成果報告書概要(和文)」より
    • Overseas
    • Data Source
      KAKENHI-PROJECT-18390465
  • [Patent] 脈絡膜新生血管のワクチン療法2008

    • Inventor(s)
      玉置泰裕 田原秀晃
    • Industrial Property Rights Holder
      東京大学
    • Filing Date
      2008-02-15
    • Data Source
      KAKENHI-PROJECT-18390465
  • [Patent] 脈絡膜新生血管のワクチン療法2007

    • Inventor(s)
      玉置泰裕、田原秀晃
    • Industrial Property Rights Holder
      国立大学法人東京大学
    • Filing Date
      2007-02-16
    • Data Source
      KAKENHI-PROJECT-18390465
  • [Presentation] 患者検体を利用したがん治療開発システムの構築2019

    • Author(s)
      田原秀晃
    • Organizer
      第26回HAB研究機構学術年会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17H01578
  • [Presentation] 患者検体の先進的利活用による医療の開発と検証2019

    • Author(s)
      田原秀晃
    • Organizer
      安全性評価研究会 第22回 春のセミナー
    • Invited
    • Data Source
      KAKENHI-PROJECT-17H01578
  • [Presentation] 免疫応答のプライミング相を制御する新規がん治療法の開発2019

    • Author(s)
      田原秀晃,溝手雄,他
    • Organizer
      第 119 回日本外科学会定期学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17H01578
  • [Presentation] Time-scale analysis of interplay between occult immunogenic tumor and immune response2015

    • Author(s)
      Marija Mojic, Marimo Sato-Matsushita, Hideaki Tahara, Ikuo Saiki, Yoshihiro Hayakawa
    • Organizer
      第44回日本免疫学会学術集会
    • Place of Presentation
      札幌コンベンションセンター(北海道札幌市)
    • Year and Date
      2015-11-18
    • Data Source
      KAKENHI-PROJECT-25461974
  • [Presentation] 腫瘍細胞表面抗原を介して侵入する標的化単純ヘルペスウイルスベクターの開発2015

    • Author(s)
      城山智貴, 内田宏昭, 大久保優, 柴田智子, 福原武志, 山口美樹, Justus B. Cohen, Joseph C. Glorioso, 渡部徹郎, 濱田洋文, 田原秀晃
    • Organizer
      第7回血液疾患免疫療法研究会
    • Place of Presentation
      東京大学本郷キャンパス(東京都文京区)
    • Year and Date
      2015-09-26
    • Data Source
      KAKENHI-PROJECT-15K15144
  • [Presentation] Novel function of NK cell to regulate cancer-associated inflammation2015

    • Author(s)
      小倉圭介、松下(佐藤) まりも、田原秀晃、済木育夫、早川芳弘
    • Organizer
      第74回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(愛知県名古屋市)
    • Year and Date
      2015-10-08
    • Data Source
      KAKENHI-PROJECT-25461974
  • [Presentation] 腫瘍細胞表面抗原を介して侵入する標的化単純ヘルペスウイルスベクターの開発2015

    • Author(s)
      城山智貴, 内田宏昭, 大久保優, 柴田智子, 福原武志, 山口美樹, Justus B. Cohen, Joseph C. Glorioso, 渡部徹郎, 濱田洋文, 田原秀晃
    • Organizer
      第7回血液疾患免疫療法研究会
    • Place of Presentation
      東京大学本郷キャンパス(東京都文京区)
    • Year and Date
      2015-09-26
    • Data Source
      KAKENHI-PROJECT-25290059
  • [Presentation] Therapeutic efficacy of modified DC2014

    • Author(s)
      Marimo Sato-Matsushita and Hideaki Tahara
    • Organizer
      第24回日本樹状細胞研究会総会
    • Place of Presentation
      山形
    • Year and Date
      2014-06-20
    • Invited
    • Data Source
      KAKENHI-PROJECT-25461974
  • [Presentation] 癌免疫療法の現状と展望2011

    • Author(s)
      田原秀晃
    • Organizer
      第15回日本がん分子標的治療学会学術集会
    • Place of Presentation
      ホテル日航東京(招待講演)
    • Year and Date
      2011-06-24
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] 癌免疫療法の現状と展望(招待講演)2011

    • Author(s)
      田原秀晃
    • Organizer
      第15回日本がん分子標的治療学会学術集会
    • Place of Presentation
      東京都
    • Year and Date
      2011-06-24
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Cancer vaccination using tumor cells in situ as the source of tumor antigens2010

    • Author(s)
      Hideaki Tahara
    • Organizer
      Working Group meeting(Invited Speaker)
    • Place of Presentation
      米国NCI(Bethesda, MD)
    • Year and Date
      2010-04-22
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Significant enhancement of antigen-specific antitumor effects of DNA vaccine with systemic administration of interleukin-232010

    • Author(s)
      米山公康、佐藤まりも、田原秀晃
    • Organizer
      日本外科学会学術総会
    • Place of Presentation
      名古屋市
    • Year and Date
      2010-04-09
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] 生体内がんワクチン療法の開発2010

    • Author(s)
      田原秀晃
    • Organizer
      日本頭頸部癌学会(特別講演)
    • Place of Presentation
      東京都
    • Year and Date
      2010-06-10
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Cancer vaccination using tumor cells in situ as the source of tumor antigens2010

    • Author(s)
      Hideaki Tahara
    • Organizer
      日本癌学会学術総会(シンポジウム)
    • Place of Presentation
      大阪
    • Year and Date
      2010-09-22
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Cancer vaccination using tumor cells in situ as the source of tumor antigens2010

    • Author(s)
      Hideaki Tahara
    • Organizer
      日本癌学会学術総会(シンポジウム)
    • Place of Presentation
      大阪、大阪国際会議場リーガロイヤルホテル大阪
    • Year and Date
      2010-09-22
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Cancer vaccination using tumor cells in situ as the source of tumor antigens2010

    • Author(s)
      田原秀晃
    • Organizer
      13th Asia Pacific-International Molecular Biology Network (A-IMBN) Symposium (Invited Speaker)
    • Place of Presentation
      Chinese Taipei
    • Year and Date
      2010-11-14
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Cancer vaccination using tumor cells in situ as the source of tumor antigens2010

    • Author(s)
      Hideaki Tahara
    • Organizer
      Vaccine Working Group meeting (Invited Speaker)
    • Place of Presentation
      米国NCI (Bethesda, MD)
    • Year and Date
      2010-04-22
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] 生体内がんワクチン療法の開発2010

    • Author(s)
      田原秀晃
    • Organizer
      日本頭頸部癌学会
    • Place of Presentation
      ウインクあいち(特別講演)
    • Year and Date
      2010-06-10
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Cancer vaccination using tumor cells in situ as the source of tumor antigens2010

    • Author(s)
      田原秀晃
    • Organizer
      13th Asia Pacific-International Molecular Biology Network(A-IMBN) Symposium(Invited Speaker)
    • Place of Presentation
      Chinese Taipei
    • Year and Date
      2010-11-14
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] 生体内に存在する腫瘍細胞を利用した癌免疫療法の開発2010

    • Author(s)
      田原秀晃
    • Organizer
      日本がん免疫学会(シンポジウム)
    • Place of Presentation
      熊本市、リバーサイドホテル熊本
    • Year and Date
      2010-07-23
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Translational research of clinical dendritic cell therapy using OK-432 and prostaglandin E2(Phase I study)2010

    • Author(s)
      Sato-Matsushita M, Kanamoto A, Katano H, Itoh A, Tahara H
    • Organizer
      14^<th> International Congress of Immunology
    • Place of Presentation
      神戸市、神戸ポートピアホテル神戸コンベンションセンター
    • Year and Date
      2010-08-27
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] 生体内に存在する腫瘍細胞を利用した2010

    • Author(s)
      田原秀晃
    • Organizer
      癌免疫療法の開発日本がん免疫学会(シンポジウム)
    • Place of Presentation
      熊本市
    • Year and Date
      2010-07-23
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Significant enhancement of antigen-specific antitumor effects of DNA vaccine with systemic administration of interleukin-232010

    • Author(s)
      米山公康、佐藤まりも、田原秀晃
    • Organizer
      日本外科学会学術総会
    • Place of Presentation
      名古屋市、名古屋国際会議場
    • Year and Date
      2010-04-09
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Translational research of clinical dendritic cell therapy using OK-432 and prostaglandin E2(Phase I study)2010

    • Author(s)
      Sato-Matsushita M, Kanamoto A, Katano H, Itoh A, Tahara H
    • Organizer
      14^th International Congress of Immunology
    • Place of Presentation
      神戸市
    • Year and Date
      2010-08-27
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Cancer vaccine against malignant melanoma using monocyte-derived dendritic cells stimulated with OK-432 and PGE22009

    • Author(s)
      佐藤まりも、田原秀晃, 他5名
    • Organizer
      日本癌学会総会
    • Place of Presentation
      横浜市
    • Year and Date
      2009-10-02
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Presentation] Cancer vaccine against malignant melanoma using monocyte-derived dendritic cells stimulated with OK-432 and PGE22009

    • Author(s)
      佐藤まりも、田原秀晃, 他5名
    • Organizer
      日本癌学会総会
    • Place of Presentation
      横浜市
    • Year and Date
      2009-10-02
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Cancer vaccination using tumor cells in situ as the source of tumor antigens2009

    • Author(s)
      田原秀晃
    • Organizer
      日本癌学会総会
    • Place of Presentation
      横浜市
    • Year and Date
      2009-10-03
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation]2009

    • Author(s)
      佐藤まりも, 金本彰, 地主将久, 片野尚子, 米山公康, 伊藤精彦, 田原秀晃
    • Organizer
      第13回日本がん免疫学会総会
    • Data Source
      KAKENHI-PROJECT-19591504
  • [Presentation] Cancer vaccine against malignant melanoma using monocyte-derived dendritic cells stimulated with OK-432 and PGE2009

    • Author(s)
      佐藤まりも, 金本彰, 片野尚子, 地主将久, 米山公康, 伊藤精彦, 田原秀晃
    • Organizer
      第68回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-19591504
  • [Presentation] Antigen-specific antitumor effects of DNA vaccine are significantly enhanced with systemic administration of interleukin(IL)-232009

    • Author(s)
      米山公康、田原秀晃, 他3名
    • Organizer
      日本免疫学会総会
    • Place of Presentation
      大阪市
    • Year and Date
      2009-12-04
    • Data Source
      KAKENHI-PROJECT-21249069
  • [Presentation] Antigen-specific antitumor effects of DNA vaccine are significantly enhanced with systemic administration of interleukin (IL)-232009

    • Author(s)
      米山公康、田原秀晃, 他3名
    • Organizer
      日本免疫学会総会
    • Place of Presentation
      大阪市
    • Year and Date
      2009-12-04
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Presentation] Cancer vaccination using tumor cells in situ as the source of tumor antigens2009

    • Author(s)
      田原秀晃
    • Organizer
      日本癌学会総会
    • Place of Presentation
      横浜市
    • Year and Date
      2009-10-03
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Presentation] Clinical dendritic cell therapy using OK-432 and prostaglandin E2 (Phase I study)2009

    • Author(s)
      佐藤まりも, 金本彰, 地主将久, 片野尚子, 米山公康, 伊藤精彦, 田原秀晃
    • Organizer
      第19回日本樹状細胞研究会
    • Data Source
      KAKENHI-PROJECT-19591504
  • [Presentation] Antigen-specific antitumor effects of DNA vaccine are significantly enhanced with systemic administration of interleukin(IL)-232009

    • Author(s)
      米山公康、田原秀晃, 他3名
    • Organizer
      日本免疫学会総会
    • Place of Presentation
      大阪市
    • Year and Date
      2009-12-04
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Presentation] Cancer vaccination using tumor cells in situ as the source of tumor antigens2009

    • Author(s)
      田原秀晃
    • Organizer
      (シンポジウム)日本癌学会総会
    • Place of Presentation
      横浜市
    • Year and Date
      2009-10-03
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Presentation] Potent Anti-tumor Immunity and both Th1 and Th17 promotion associated with IL-23 administration (Symposium)2008

    • Author(s)
      Hideaki Tahara
    • Organizer
      Annual Meeting, International Society of Biological Therapy for Cancer
    • Place of Presentation
      米国 San Diego
    • Year and Date
      2008-10-31
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Presentation] Potent Anti-tumor Immunity and both Th1 and Th17 promotion associated with IL-23 administration (Symposium) Annual Meeting2008

    • Author(s)
      Hideaki Tahara
    • Organizer
      International Society of Biological Therapy for Cancer
    • Place of Presentation
      米国San Diego
    • Year and Date
      2008-10-31
    • Data Source
      KAKENHI-PROJECT-20015016
  • [Presentation] PRODUCTION OF CURRENT GMP-COMPLIANT VIRAL VECTORS FOR EARLY PHASE CLINICAL TRIALS2007

    • Author(s)
      Katsunori Sasaki, Hideaki Tahara, et. al.
    • Organizer
      Japanese Society of Gene Therapy
    • Place of Presentation
      Nagoya
    • Year and Date
      2007-06-30
    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-17209042
  • [Presentation] Potent anti-tumor effects of combination therapy using Interleukin-23 and alpha-galactosylceramide2007

    • Author(s)
      Kaneda H., Tahara H., et. al.
    • Organizer
      Annual Meeting of American Association of Cancer Research
    • Place of Presentation
      USA
    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Presentation] Potent anti tumor effects of combination therapy using Interleukin-23 and alpha-galactosylceramide.2007

    • Author(s)
      Kaneda H., Tahara H. et. al
    • Organizer
      American Association of Cancer Research
    • Place of Presentation
      USA
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Presentation] ESTABLISHMENT OF THE SYSTEM TO SUPPORT EX VTVO CELL MANIPULATION APPROPRIATE FOR CLINICAL TRIALS OF GENE THERAPY2007

    • Author(s)
      Hisako Katano, Hideaki Tahara, et al
    • Organizer
      Japanese Society of Gene Therapy
    • Place of Presentation
      Nagoya
    • Year and Date
      2007-06-30
    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-17209042
  • [Presentation] ESTABLISHMENT OF THE SYSTEM TO SUPPORT EX VIVO CELL MANIPULATION APPROPRIATE FOR CLINICAL TRIALS OF GENE THERAPY2007

    • Author(s)
      片野尚子, 田原秀晃, 他
    • Organizer
      日本遺伝子治療学会
    • Place of Presentation
      名古屋
    • Year and Date
      2007-06-30
    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-17209042
  • [Presentation] PRODUCTION OF CURRENT GMP-COMPLIANT VIRAL VECTORS FOR EARLY PHASE CLINICAL TRIALS2007

    • Author(s)
      佐々木勝則, 田原秀晃, 他
    • Organizer
      日本遺伝子治療学会
    • Place of Presentation
      名古屋
    • Year and Date
      2007-06-30
    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-17209042
  • [Presentation] Potent anti-tumor effects of combination therapy using Interleukin-23 and alpha-galactosylceramide.2007

    • Author(s)
      Kaneda H., Tahara H., et. al.
    • Organizer
      American Association of Cancer Research
    • Place of Presentation
      USA
    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-18612002
  • [Presentation] Therapeutic efficacy of the treatment with monoclonal antibody and dendritic cells genetically modified to express IL-12 in vivo.

    • Author(s)
      Marimo Sato-Matsushita and Hideaki Tahara
    • Organizer
      第23回日本樹状細胞研究会
    • Place of Presentation
      京都国際会館、京都
    • Data Source
      KAKENHI-PROJECT-25461974
  • [Presentation] NK cell IFN-gamma as a primary effector pathway for controlling tumor growth

    • Author(s)
      小倉圭介, 松下(佐藤)まりも, 田原秀晃, 済木育夫, 早川芳弘
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-25461974
  • [Presentation] Cancer immune escalation process triggered by activation of gamma-delta T17 cells through MyD88/IL-23 cascade

    • Author(s)
      Yoshitaka Kimura, Marimo Sato-Matsushita, Takayuki Yoshimoto, Hideaki Tahara, Ikuo Saiki, Tatsuro Irimura, Yoshihiro Hayakawa
    • Organizer
      第42回日本免疫学会学術集会
    • Place of Presentation
      幕張メッセ、千葉
    • Data Source
      KAKENHI-PROJECT-25461974
  • 1.  TAKAYAMA Takuya (10332579)
    # of Collaborated Projects: 10 results
    # of Collaborated Products: 10 results
  • 2.  Uchida Hiroaki (20401250)
    # of Collaborated Projects: 9 results
    # of Collaborated Products: 13 results
  • 3.  TSUNODA Takuya (30275359)
    # of Collaborated Projects: 6 results
    # of Collaborated Products: 2 results
  • 4.  BECK Yoshifumi (70199454)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 1 results
  • 5.  ICHIKAWA Naoya (60251451)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 0 results
  • 6.  KATANO Hisako (50376620)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 3 results
  • 7.  TANI Kenzaburou (00183864)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 3 results
  • 8.  SATO Marimo (50401253)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 16 results
  • 9.  SASAKI Katsunori (60336394)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 2 results
  • 10.  Mika Hamada-Uematsu (90769449)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 3 results
  • 11.  KANAMOTO Akira (10386021)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 6 results
  • 12.  JIMUSHI Masahisa (40318085)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 5 results
  • 13.  KATAOKA Kazunori (00130245)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 14.  KITAMURA Yoshihiro (10202037)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 15.  ANDO Yuichi (00262080)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 16.  YAMAGUCHI MIKI (10530454)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 3 results
  • 17.  ITO Akihiko (90241984)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 8 results
  • 18.  NAKA Nokenjl (00315061)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 19.  NISHIYAMA Nobuhiro (10372385)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 20.  KUWANO Michihiko (80037431)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 21.  NAKAMUTA Takahumi (70432911)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 22.  KATANO Harutaka (70321867)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 23.  TAKEDA Yasutaka (40163422)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 24.  TSUBURA Airo (90098137)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 25.  SHIMIZU Motomu (10124463)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 26.  TOJYO Arinobu (00211681)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 27.  TAMAKI Yasuhiro (20217178)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 28.  YANAGI Yasuo (90376442)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 29.  FURUKAWA Takahisa (50260609)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 30.  KONDO Mineo (80303642)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 31.  NAGAMURA Fumitaka (90282491)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 32.  OOKI Momoyo (10306269)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 33.  NAGAMURA Tokiko (90332585)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 34.  SATO Noriharu (90162461)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 35.  KOJIMA MASAKI (90277252)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 36.  FUKUHARA TAKESHI (20359673)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 37.  中崎 有恒 (00346850)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 38.  曽田 泰 (00361618)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 39.  浅野 茂隆 (50134614)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 40.  柳衛 宏宣 (30212278)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 41.  丸山 一雄 (30130040)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 42.  河上 裕 (50161287)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 43.  濱田 洋文 (00189614)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 44.  藤原 俊義 (00304303)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 45.  土岐 祐一郎 (20291445)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 46.  田中 晃司 (70621019)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 47.  HARAGUCHI Takeshi
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 48.  KUNITA Akiko
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 49.  入村 達郎
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 50.  竹田 和由
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 51.  早川 芳弘
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 52.  八木田 秀雄
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 53.  吉山 裕規
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 54.  木下 一郎
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 55.  瀬谷 司
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 56.  松本 美佐子
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 57.  井上 徳光
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 58.  志馬 寛明
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 59.  押海 裕之
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 60.  金子 美華
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 61.  西岡 安彦
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 62.  尹 浩信
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 63.  高木 理彰
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 64.  宮川 世志幸
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 65.  Glorioso Joseph C., III
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 66.  高浜 洋介
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to connect your ORCID iD to this researcher?
* This action can be performed only by the researcher themselves.

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi